ATTR-CM
Clinical trials for ATTR-CM explained in plain language.
Never miss a new study
Get alerted when new ATTR-CM trials appear
Sign up with your email to follow new studies for ATTR-CM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New training program aims to catch rare heart disease earlier
Diagnosis Recruiting nowThis study enrolls about 4,000 adults aged 60 and older with heart failure who are at high risk for ATTR amyloidosis, a rare disease that stiffens the heart. Doctors receive special training on how to spot and diagnose the condition using standard tests. The goal is to see if thi…
Matched conditions: ATTR-CM
Phase: NA • Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple scan unlock better heart treatment?
Knowledge-focused Recruiting nowThis study tests a new PET scan technique to better track heart damage in people with a condition called ATTR-CM, a progressive heart muscle disease. Researchers will scan 140 participants to see if the imaging can show how well treatments are working. The goal is to improve moni…
Matched conditions: ATTR-CM
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Massive global study to track rare heart and nerve disease in real life
Knowledge-focused Recruiting nowThis study will follow about 1,850 people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers will collect information on patients' health, treatments, and outcomes over time to better understand the disease and how current therapies work in every…
Matched conditions: ATTR-CM
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC